Are Cephalosporins Appropriate for the Treatment of Acute Otitis Media in This Era of Increasing Antimicrobial Resistance Among Common Respiratory Tract Pathogens?
Restricted accessOtherFirst published online March, 2005
Are Cephalosporins Appropriate for the Treatment of Acute Otitis Media in This Era of Increasing Antimicrobial Resistance Among Common Respiratory Tract Pathogens?
Pelton SI. Otitis media. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2nd ed.New York: Churchill Livingstone; 2003:190-198.
2.
Paradise JL, Rockette HE, Colborn DK, et al.Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
3.
Dowell SF, Marcy SM, Phillips WR, et al.Otitis media: principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(suppl):165-171.
4.
Klein JO. Otitis media. Clin Infect Dis. 1994;19:823-833.
5.
Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort [abstract]. Pediatrics. 2000;105:1323.
6.
Dowell SF, Butler JC, Giebink GS, et al., and the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Acute otitis media: management and surveillance in an era of pneumococcal resistance. A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group [erratum appears in Pediatr Infect Dis J 1999;18:341]. Pediatr Infect Dis J. 1999;18:1-9.
7.
Dagan R, Hoberman A, Johnson C, etal. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr Infect Dis J. 2001;20:829-837.
8.
Leibovitz E, Satran R, Piglansky L, et al.Can acute otitis media caused by Haemophilus influenzae be distinguished from that caused by Streptococcus pneumoniae? Pediatr Infect Dis J. 2003;22:509-515.
9.
Jacobs MR, Felmingham D, Appelbaum PC, Grüneberg RN, and the Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52:229-246.
10.
US Pediatric Surveillance Data 2001-2002. Surveillance Data Inc., Focus Technologies Inc., Plymouth Meeting, PA.
11.
James LP, Abdel-Rahman S, Farrar HC, Jacobs RF. Antimicrobial agents. In: Long SS, Pickering LK, Prober CG, eds. Principles and Practice of Pediatric Infectious Diseases, 2nd ed.New York: Churchill Livingstone; 2003:1458-1467.
12.
Hakenbeck R, Kaminski K, König A, et al.Penicillin-binding proteins in β-lactam-resistant Streptococcus pneumoniae. Microb Drug Resist. 1999;5:91-99.
13.
National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: twelfth informational supplement: approved standard M100-S12. Wayne, PA: National Committee for Clinical Laboratory Standards; 2002.
14.
Dagan R, Abramson O, Leibovitz E, et al.Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J. 1996;15:980-985.
15.
Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J. 2000;19:S57-S65.
16.
Dagan R, Leibovitz E, Greenberg D, et al.Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776-782.
17.
Hoberman A, Marchant CD, Kaplan SL, Feldman S. Treatment of acute otitis media consensus recommendations. Clin Pediatr. 2002;41:373-390.
18.
American Academy of Pediatrics and American Academy of Family Physicians Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465.
19.
Gehanno P, Nguyen L, Barry B, et al.Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media [erratum appears in Antimicrob Agents Chemother. 1999;43:1532]. Antimicrob Agents Chemother. 1999;43:16-20.
20.
Appelbaum PC. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Clin Infect Dis. 2000;31(suppl 2):S29-S34.
21.
Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26:1-12.
22.
Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259.
23.
Jacobs MR. Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters. Clin Microbiol Infect. 2001;7:589-596.
24.
Liu P, Müller M, Derendorf H. Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents. 2002;19:285-290.
25.
Harrison CJ. Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy. Pediatr Infect Dis J. 1997;16(suppl):S12-S16.
26.
Adler M, McDonald PJ, Trostmann U, et al.Cefdinir versus amoxicillin/clavulanic acid in the treatment of suppurative acute otitis media in children. Eur J Clin Microbiol Infect Dis. 1997;16:214-219.
27.
Block SL, McCarty JM, Hedrick JA, et al., and the Cefdinir Otitis Media Study Group. Comparative safety and efficacy of cefdinir vs amoxicillin/clavulanate for treatment of suppurative acute otitis media in children. Pediatr Infect Dis J. 2000;19:S159-S165.
28.
Gooch WM III, Philips A, Rhoades R, et al.Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media. Pediatr Infect Dis J. 1997;16(suppl):S21-S24.
29.
Mandel EM, Casselbrant ML, Kurs-Lasky M, Bluestone CD. Efficacy of ceftibuten compared with amoxicillin for otitis media with effusion in infants and children. Pediatr Infect Dis J. 1996;15:409-414.
30.
McLinn SE, McCarty JM, Perrotta R, et al., and members of the Ceftibuten Otitis Media United States Study Group. Multicenter controlled trial comparing ceftibuten with amoxicillin/clavulanate in the empiric treatment of acute otitis media. Pediatr Infect Dis J. 1995;14:S108-S114.
31.
Mendelman PM, Del Beccaro MA, McLinn SE, Todd WM. Cefpodoxime proxetil compared with amoxicillinclavulanate for the treatment of otitis media. J Pediatr. 1992;121:459-465.
32.
Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the “Pollyanna phenomenon.”J Pediatr. 1992;120:72-77.
33.
Dagan R, McCracken GH Jr. Flaws in design and conduct of clinical trials in acute otitis media. Pediatr Infect Dis J. 2002;21:894-902.
34.
Pichichero ME. Short course antibiotic therapy for respiratory infections: a review of the evidence. Pediatr Infect Dis J. 2000;19:929-937.
35.
Cohen R, Levy C, Boucherat M, et al.Five vs ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J. 2000;19:458-463.
36.
Cohen R, Navel M, Grunberg J, et al.One dose ceftriaxone vs ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora. Pediatr Infect Dis J. 1999;18:403-409.
37.
Cohen R, Levy C, Boucherat M, et al.A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr. 1998;133:634-639.
38.
Kozyrskyj AL, Hildes-Ripstein E, Longstaffe SEA, et al.Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA. 1998;279:1736-1742.
39.
Pichichero ME, Marsocci SM, Murphy ML, et al.A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media. Otolaryngol Head Neck Surg. 2001;124:381-387.
40.
Paradise SL. Short-course antimicrobial treatment for acute otitis media: not best for infants and young children. JAMA. 1997;278:1640-1642.
41.
Heikkinen T, Saeed KA, McCormick DP, et al.A single intramuscular dose of ceftriaxone changes nasopharyngeal bacterial flora in children with acute otitis media. Acta Pædiatr. 2000;89:1316-1321.
42.
Dagan R, Leibovitz E, Cheletz G, et al.Antibiotic treatment in acute otitis media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment. J Infect Dis. 2001;183:880-886.
43.
Dabernat H, Geslin P, Megraud F, et al.Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother. 1998;41:253-258.
44.
Haiman T, Leibovitz E, Piglansky L, et al.Dynamics of pneumococcal nasopharyngeal carriage in children with nonresponsive acute otitis media treated with two regimens of intramuscular ceftriaxone. Pediatr Infect Dis J. 2002;21:642-647.
